Scarica l'app Stockscreener
15.60
1.70%
-0.27
Dopo l'orario di chiusura:
15.53
-0.07
-0.45%
Precedente Chiudi:
$15.87
Aprire:
$16.09
Volume 24 ore:
880.42K
Relative Volume:
0.89
Capitalizzazione di mercato:
$762.02M
Reddito:
-
Utile/perdita netta:
$-695.98M
Rapporto P/E:
-0.0475
EPS:
-328.6331
Flusso di cassa netto:
$-143.65M
1 W Prestazione:
-0.92%
1M Prestazione:
+15.47%
6M Prestazione:
-48.38%
1 anno Prestazione:
+11.43%
Intervallo 1D:
$15.41
$16.15
Intervallo di 1 settimana:
$15.20
$16.55
Portata 52W:
$2.622
$65.80
Vor Biopharma Inc Stock (VOR) Company Profile
Nome
Vor Biopharma Inc
Settore
Industria
Telefono
617-655-6580
Indirizzo
500 BOYLSTON STREET, BOSTON
Compare VOR vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
15.60 | 775.21M | 0 | -695.98M | -143.65M | -328.63 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-30 | Iniziato | Jefferies | Buy |
| 2026-03-19 | Iniziato | Wells Fargo | Overweight |
| 2026-01-09 | Iniziato | Citigroup | Buy |
| 2025-12-17 | Iniziato | TD Cowen | Buy |
| 2025-12-09 | Iniziato | JP Morgan | Overweight |
| 2025-11-25 | Ripresa | Wedbush | Neutral |
| 2025-10-15 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-09-24 | Aggiornamento | Stifel | Hold → Buy |
| 2025-06-30 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2022-07-26 | Iniziato | Wedbush | Outperform |
| 2022-04-27 | Iniziato | Goldman | Neutral |
| 2021-12-17 | Iniziato | H.C. Wainwright | Buy |
| 2021-12-03 | Iniziato | Robert W. Baird | Outperform |
| 2021-12-02 | Iniziato | Oppenheimer | Outperform |
| 2021-10-19 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-03-25 | Iniziato | B. Riley Securities | Buy |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-03-03 | Iniziato | Evercore ISI | Outperform |
| 2021-03-02 | Iniziato | Goldman | Sell |
| 2021-03-02 | Iniziato | Stifel | Buy |
Mostra tutto
Vor Biopharma Inc Borsa (VOR) Ultime notizie
Ra Capital Management, L.P. Sells 530,610 Shares of Vor Biopharma (NASDAQ:VOR) Stock - MarketBeat
RA Capital sells Vor Biopharma (VOR) shares worth $11.8 million - Investing.com
Insider Selling: Vor Biopharma (NASDAQ:VOR) Director Sells 153,735 Shares of Stock - MarketBeat
Vor Biopharma (NASDAQ:VOR) Director Sells $858,840.44 in Stock - MarketBeat
H.C. Wainwright lowers Vor Biopharma price target to $31 By Investing.com - Investing.com Australia
HC Wainwright Has Lowered Expectations for Vor Biopharma (NASDAQ:VOR) Stock Price - MarketBeat
VOR Maintains Buy Rating by HC Wainwright & Co. -- Price Target Lowered to $31 - GuruFocus
Vor Biopharma, Inc. (VOR) PT Lowered to $31 at H.C. Wainwright - StreetInsider
Vor Biopharma Inc. (NASDAQ:VOR) Short Interest Up 66.5% in March - MarketBeat
Vor Biopharma(VOR.US) 10% Shareholder Sells US$10.23 Million in Common Stock - Moomoo
Ra capital sells Vor Biopharma (VOR) shares worth $10.2 million By Investing.com - Investing.com India
Vor Biopharma (NASDAQ:VOR) Director Sells $2,242,984.59 in Stock - MarketBeat
Ra Capital Management, L.P. Sells 484,104 Shares of Vor Biopharma (NASDAQ:VOR) Stock - MarketBeat
Vor Biopharma (NASDAQ:VOR) Director Sells $13,041.00 in Stock - MarketBeat
Ra capital sells Vor Biopharma (VOR) shares worth $10.2 million - Investing.com
RA Capital trims Vor Biopharma (VOR) stake while keeping 19.9% ownership - Stock Titan
RA Capital Healthcare Fund trims Vor Biopharma (NASDAQ: VOR) stake, still holds 3.9M shares - Stock Titan
VOR Forecast, Price Target & Analyst Ratings | VOR BIOPHARMA INC (NASDAQ:VOR) - ChartMill
Vor Biopharma (VOR) Financials 2026Income Statement and Balance Sheet $VOR - MarketBeat
Vor Biopharma (VOR) CMO discloses options and RSU-based stake - Stock Titan
Dow Update: What are analysts price targets for Vor Biopharma IncEarnings Recap Report & Precise Trade Entry Recommendations - baoquankhu1.vn
RA Capital (NASDAQ: VOR) discloses 19.9% Vor Biopharma ownership cap - Stock Titan
Vor Biopharma: It's A Game Of Wait And See (NASDAQ:VOR) - Seeking Alpha
Bull Bear: What are analysts price targets for Vor Biopharma IncMarket Risk Summary & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Stifel reiterates Vor Biopharma stock rating on drug potential By Investing.com - Investing.com India
Stifel reiterates Vor Biopharma stock rating on drug potential - Investing.com
Vor Biopharma (VOR) Reiterated at Buy by Stifel After Meetings About Telitacicept Potential - StreetInsider
Aug Wrap: Should you buy the dip on Vor Biopharma Inc2026 Performance Recap & Fast Moving Market Watchlists - baoquankhu1.vn
Aug Momentum: Is Vor Biopharma Inc currently under institutional pressure2026 Recap & Daily Oversold Bounce Ideas - baoquankhu1.vn
Vor Biopharma (NASDAQ:VOR) Shares Gap Down on Insider Selling - MarketBeat
Vor Biopharma(VOR.US) 10% Shareholder Sells US$14.52 Million in Common Stock - Moomoo
Ra capital sells Vor Biopharma (VOR) shares worth $14.5 million By Investing.com - Investing.com Canada
Insider Selling: Vor Biopharma (NASDAQ:VOR) Director Sells 260,000 Shares of Stock - MarketBeat
Ra capital sells Vor Biopharma (VOR) shares worth $14.5 million - Investing.com
RA Capital trims Vor Biopharma (VOR) stake with 849K-share sale - Stock Titan
Vor Biopharma (NASDAQ:VOR) Trading Down 5.8%Here's Why - marketbeat.com
Wall Street analysts predict a 107.82% upside in Vor Biopharma (VOR): Here's what you should know - MSN
Vor Biopharma Inc. (NASDAQ:VOR) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Insider Selling: Vor Biopharma (NASDAQ:VOR) Director Sells 589,257 Shares of Stock - MarketBeat
Vor Biopharma (VOR) upgraded to buy: Here's why - MSN
Wall Street Zen Upgrades Vor Biopharma (NASDAQ:VOR) to Hold - MarketBeat
Jefferies initiates coverage of Vor Biopharma (VOR) with buy recommendation - MSN
Vor Biopharma (VOR) Upgraded to Buy: Here's Why - Yahoo Finance
Wall Street experts anticipate that Vor Biopharma (VOR) could surge by 107.82%: Key Information You Need to Know - bitget.com
Wall Street Analysts Predict a 107.82% Upside in Vor Biopharma (VOR): Here's What You Should Know - Yahoo Finance
Chen Yu and TCG entities hold 10.5% of Vor Biopharma (NASDAQ: VOR) - Stock Titan
TCG Crossover funds in Vor (VOR) disclose 2,836,539 common shares - Stock Titan
Vor Biopharma (VOR) ownership update shows RA Capital at 19.9% - Stock Titan
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Vor Bio announces $75M private placement - MSN
Wedbush Maintains 'Neutral' Rating, Raises Price Target for Vor Biopharma (VOR) to $15 | VOR Stock News - gurufocus.com
Vor Biopharma Inc Azioni (VOR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):